About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Diabetes and Vascular Disease Research
›
top-articles
Diabetes and Vascular Disease Research
1.7
(top 50%)
impact factor
889
(top 20%)
papers
20.9K
(top 10%)
citations
64
(top 10%)
h
-index
1.7
(top 50%)
impact factor
985
all documents
22.2K
doc citations
100
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials
Diabetes and Vascular Disease Research
2015
333
2
Probing SGLT2 as a therapeutic target for diabetes: Basic physiology and consequences
Diabetes and Vascular Disease Research
2015
298
3
Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome
Diabetes and Vascular Disease Research
2005
273
4
Metformin therapy and clinical uses
Diabetes and Vascular Disease Research
2008
252
5
Homocysteine and cardiovascular disease: a review of the evidence
Diabetes and Vascular Disease Research
2007
235
6
Metabolic syndrome, or What you will: definitions and epidemiology
Diabetes and Vascular Disease Research
2007
228
7
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients
Diabetes and Vascular Disease Research
2008
227
8
The endothelium and vascular inflammation in diabetes
Diabetes and Vascular Disease Research
2007
223
9
Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA
®
)
Diabetes and Vascular Disease Research
2015
197
10
Dipeptidyl peptidase IV (DPP IV) inhibitors: a newly emerging drug class for the treatment of type 2 diabetes
Diabetes and Vascular Disease Research
2006
195
11
Review article: Coagulation and fibrinolysis in diabetes
Diabetes and Vascular Disease Research
2010
186
12
Review article: Platelet abnormalities in diabetes mellitus
Diabetes and Vascular Disease Research
2010
184
13
Cellular and molecular mechanisms of endothelial dysfunction in diabetes
Diabetes and Vascular Disease Research
2013
177
14
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD – Summary
Diabetes and Vascular Disease Research
2014
173
15
Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift
Diabetes and Vascular Disease Research
2019
169
16
New perspectives on the management of diabetic peripheral neuropathic pain
Diabetes and Vascular Disease Research
2006
164
17
Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes
Diabetes and Vascular Disease Research
2019
155
18
A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE
-/-
mouse model
Diabetes and Vascular Disease Research
2011
152
19
Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study
Diabetes and Vascular Disease Research
2006
150
20
The impact of smoking on the development of diabetes and its complications
Diabetes and Vascular Disease Research
2017
149
21
The insulin resistance syndrome: physiological considerations
Diabetes and Vascular Disease Research
2007
140
22
Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: Rationale for the active-comparator CAROLINA trial
Diabetes and Vascular Disease Research
2013
132
23
Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology
Diabetes and Vascular Disease Research
2013
132
24
Impaired glucose tolerance and impaired fasting glucose — a review of diagnosis, clinical implications and management
Diabetes and Vascular Disease Research
2005
128
25
Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus
Diabetes and Vascular Disease Research
2016
122
26
The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE
−/−
mouse model
Diabetes and Vascular Disease Research
2013
121
27
Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis
Diabetes and Vascular Disease Research
2007
120
28
All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals
Diabetes and Vascular Disease Research
2005
116
29
Thrifty genes for obesity and the metabolic syndrome — time to call off the search?
Diabetes and Vascular Disease Research
2006
115
30
Alpha-glucosidase inhibitors 2012 – cardiovascular considerations and trial evaluation
Diabetes and Vascular Disease Research
2012
115
31
Initial experience with GLP-1 treatment on metabolic control and myocardial function in patients with type 2 diabetes mellitus and heart failure
Diabetes and Vascular Disease Research
2004
111
32
The nuclear receptors Rev-erbs and RORs integrate circadian rhythms and metabolism
Diabetes and Vascular Disease Research
2008
111
33
Epidemiology of paediatric metabolic syndrome and type 2 diabetes mellitus
Diabetes and Vascular Disease Research
2007
110
34
Review article: Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus
Diabetes and Vascular Disease Research
2010
110
35
Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents
Diabetes and Vascular Disease Research
2008
109
36
Oxidative stress, antioxidant status and lipid profile in the saliva of type 2 diabetics
Diabetes and Vascular Disease Research
2011
109
37
Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease
Diabetes and Vascular Disease Research
2012
106
38
Gaps and barriers in the control of blood glucose in people with type 2 diabetes
Diabetes and Vascular Disease Research
2017
102
39
Cardiovascular safety of liraglutide assessed in a patient-level pooled analysis of phase 2—3 liraglutide clinical development studies
Diabetes and Vascular Disease Research
2011
101
40
Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitor
Diabetes and Vascular Disease Research
2015
99
41
Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases
Diabetes and Vascular Disease Research
2018
97
42
Evaluation of sexual function in women with type 2 diabetes mellitus
Diabetes and Vascular Disease Research
2009
94
43
The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: A systematic review and meta-analysis
Diabetes and Vascular Disease Research
2018
88
44
Cardiac autonomic diabetic neuropathy
Diabetes and Vascular Disease Research
2008
86
45
Resveratrol ameliorates diabetic vascular inflammation and macrophage infiltration in
db/db
mice by inhibiting the NF-κB pathway
Diabetes and Vascular Disease Research
2014
85
46
Role of endoplasmic reticulum stress signalling in diabetic endothelial dysfunction and atherosclerosis
Diabetes and Vascular Disease Research
2017
83
47
Mammalian hibernation: a naturally reversible model for insulin resistance in man?
Diabetes and Vascular Disease Research
2008
82
48
Dapagliflozin attenuates human vascular endothelial cell activation and induces vasorelaxation: A potential mechanism for inhibition of atherogenesis
Diabetes and Vascular Disease Research
2018
82
49
Complement C3 is a novel plasma clot component with anti-fibrinolytic properties
Diabetes and Vascular Disease Research
2012
79
50
GLP-1 receptor agonists: A clinical perspective on cardiovascular effects
Diabetes and Vascular Disease Research
2012
78
site/software ©
exaly
; All materials licenced under
CC by-SA
.